MétaCan
Menu
Back to cohort

Measuring compliance to capecitabine in colon cancer: A comparison of administrative data and medical records.

2015· article· en· W2590664248 on OpenAlexaffabout
Adam Amlani, Aalok Kumar, Winson Y. Cheung

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicEconomic and Financial Impacts of Cancer
Canadian institutionsUniversity of CalgaryBC Cancer Agency
Fundersnot available
KeywordsMedicineCapecitabineConcordanceColorectal cancerMedical recordInternal medicineCohortMedical prescriptionCancerPharmacyCancer registryPopulationStage (stratigraphy)SurgeryFamily medicine

Abstract

fetched live from OpenAlex

531 Background: Studies of administrative data indicate that compliance with oral anti-neoplastic agents, including capecitabine, is suboptimal. Using a population-based cohort of colon cancer, our aim was to evaluate the proportion of patients deemed non-compliant that actually had a reasonable indication for not adhering to their prescribed oral systemic therapy. Methods: Consecutive patients diagnosed with stage III colon cancer from 2008 to 2010, referred to any 1 of 5 regional cancer centers in British Columbia, Canada, and who initiated at least 1 cycle of oral adjuvant capecitabine within 12 weeks of curative resection were reviewed. Administrative data from the provincial oncology pharmacy database were analyzed to assess for non-compliance, which was defined as any prescription refill delays of >/=1 week from the end date of the preceding cycle. Electronic medical records were abstracted to examine the factors, if any, which contributed to non-compliance. We compared administrative vs. medical record data to determine the level of concordance and the appropriateness of non-compliance. Results: We included 752 patients: median age was 70 years (IQR 35-87), 56% were men, and 86% had ECOG 0/1. Administrative data showed that 413 patients were non-compliant: 230 (56%) and 183 (44%) had 1 and >/=2 late refills, respectively. In this group, a total of 2095 cycles of capecitabine were delivered among which 688 (33%) treatment delays occurred. No differences in baseline characteristics were observed between individuals who were compliant and those who were not (all p>0.05). Of the 688 prescription delays that were ascertained from administrative data, medical records demonstrated that 30 (4%) were misclassified. From the remainder, the majority were attributable to valid reasons, including: 339 (49%) toxicities necessitating time off therapy; 170 (25%) physician discretion; 40 (6%) travel requiring adjustment to treatment schedule; and 6 (1%) patient refusal. Only 103 (15%) cases were considered as true non-compliance. Conclusions: Using administrative data alone to measure oral drug compliance without corroborating with medical records may overestimate the degree of non-adherence.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.060

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.037
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0040.007
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.694
GPT teacher head0.531
Teacher spread0.163 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicEconomic and Financial Impacts of CancerFrench-language works237,207